NCT04956627View on ClinicalTrials.gov

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Healthy Participants
Interventions
DRUG

BMS-986166

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Extended Phenytoin Sodium

Specified dose on specified days

DRUG

Gemfibrozil

Specified dose on specified days

Trial Locations (1)

08009

Hassman Research Institute, Berlin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY